Blu Build Featured on WTAT-TV in Charleston, SC

Jan 31, 2019

The world’s first use of the Blu Build Cesium-131 brachytherapy delivery system to treat prostate cancer at Hollings Cancer Center is an important development for prostate cancer patients and their doctors.  Here’s the WTAT-TV report.

Investor Relations:

Mark Levin

Global IR Group
(501) 255-1910

Media and Public Relations:

Sharon Schultz 

(302) 539-3747

About Us

Isoray passionately designs and develops innovative and personalized brachytherapy products that effectively treat many forms of cancer. We believe in pioneering solutions for life beyond your cancer.

Patients & Families

Cesium Blu
Prostate Cancer
Treatment Areas
Find a Doc

Doctors & Clinicians

Cesium Blu
The Data
Contact Us
Our Products

Our Company

About Us
Careers
Contact Us
Newsroom
Investors

 

Copyright © 2019 Isoray Inc.

Terms of Use        Privacy Policy

Disclosure: The physicians featured on this website may have prior or current relationships with Isoray. These relationships may include, for example: membership on Isoray’s Advisory Board; participation as a clinical investigator in research conducted on Isoray products; provision of consultation or training services; or engagement as a prospective partner in the development of new products. Many of these physicians have received or continue to receive compensation from Isoray in one form or another. The principal nature of a specific physician’s relationship is disclosed on this website adjacent to language featuring that physician.